These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8731310)

  • 1. [Heart hypertrophy. Determinant factors and molecular mechanisms].
    Batlouni M
    Arq Bras Cardiol; 1995 Dec; 65(6):533-9. PubMed ID: 8731310
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathophysiological considerations in left ventricular hypertrophy.
    Frohlich ED
    J Clin Hypertens; 1987 Mar; 3(1):54-65. PubMed ID: 2952767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamics and other determinants in development of left ventricular hypertrophy.
    Frohlich ED
    Fed Proc; 1983 Jul; 42(10):2709-15. PubMed ID: 6222919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myocardial hypertrophy and fibrosis. New connections with the renin-angiotensin-aldosterone system].
    Karlberg BE
    Lakartidningen; 1993 Jan; 90(1-2):35-6. PubMed ID: 8421400
    [No Abstract]   [Full Text] [Related]  

  • 5. Left ventricular hypertrophy in hypertension: etiology, treatment, and controversies.
    Phillips RA; Diamond JA; Gharavi A
    Mt Sinai J Med; 1998 Mar; 65(2):97-103. PubMed ID: 9520512
    [No Abstract]   [Full Text] [Related]  

  • 6. [Variants of heart remodeling in essential hypertension: prevalence and determinants].
    Konradi AO; Rudomanov OG; Zakharov DV; Vakhrameeva NV; Krutikov AN; Iakovleva OI; Shliakhto EV
    Ter Arkh; 2005; 77(9):8-16. PubMed ID: 16281481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of left ventricular hypertrophy in hypertension. Report of an electrocardiographic and an echocardiographic study.
    Dal Palù C; Zamboni S; Lusiani L; Pagnan A; Ambrosio GB
    J Clin Hypertens; 1987 Jun; 3(2):211-5. PubMed ID: 2956377
    [No Abstract]   [Full Text] [Related]  

  • 8. Obese and nonobese patients with essential hypertension show similar N-terminal proBNP plasma levels.
    Cortés R; Otero MR; Morillas P; Roselló-Lletí E; Grigorian L; Martínez-Dolz L; de Burgos FG; Calabuig JR; Soria F; Lozano T; Portolés M; Bertomeu V
    Am J Hypertens; 2008 Jul; 21(7):820-5. PubMed ID: 18443568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Regression of left ventricular hypertrophy in hypertensive patients].
    Bosa Ojeda F; García González M; Domínguez Rodríguez A; Barragán Acea A; Miralles Ibarra JM; Lacalzada Almeida J; de Armas Trujillo D
    Rev Esp Cardiol; 1997; 50 Suppl 4():74-6. PubMed ID: 9411592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventricular arrhythmias: Q-T prolongation and left ventricular hypertrophy in adult Nigerians with hypertensive heart disease.
    Opadijo OG; Omotoso AB; Araoye MA
    Niger Postgrad Med J; 2003 Jun; 10(2):76-8. PubMed ID: 14567039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is leptin an independent risk factor for development of left ventricular hypertrophy in obese hypertensive patients?].
    Kiliç T
    Anadolu Kardiyol Derg; 2008 Oct; 8(5):347-9. PubMed ID: 18849225
    [No Abstract]   [Full Text] [Related]  

  • 12. Inappropriate left ventricular mass and angiotensin converting enzyme gene polymorphism.
    Celentano A; Pietropaolo I; Palmieri V; Di Palma Esposito N; Crivaro M; Cirillo F; Cerbone A; Galderisi M; de Simone G
    J Hum Hypertens; 2001 Nov; 15(11):811-3. PubMed ID: 11687927
    [No Abstract]   [Full Text] [Related]  

  • 13. [Relationship between genotype of angiotensin converting enzyme gene and left ventricular hypertrophy in Chinese hypertensives].
    Shen D; Ha D; Bai C
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Dec; 15(6):364-6. PubMed ID: 9845769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arterial hypertension, left ventricular geometry and QT dispersion in a middle-aged Estonian female population.
    Shipilova T; Pshenichnikov I; Kaik J; Volozh O; Abina J; Kalev M; Lass J; Karai D
    Blood Press; 2003; 12(1):12-8. PubMed ID: 12699130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury.
    du Toit EF; Nabben M; Lochner A
    Basic Res Cardiol; 2005 Jul; 100(4):346-54. PubMed ID: 15821998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From hypertension to heart failure: what have we learned?
    Wilson PW
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V1-10. PubMed ID: 10526697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of aldosterone in left ventricular hypertrophy in hypertension.
    Matsumura K; Fujii K; Oniki H; Oka M; Iida M
    Am J Hypertens; 2006 Jan; 19(1):13-8. PubMed ID: 16461184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension in obesity.
    Redon J
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):344-53. PubMed ID: 11887431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The cardiac renin-angiotensin system and its role in ventricular hypertrophy associated with arterial hypertension].
    Rubattu S; Volpe M; Raman V; Lindpaintner K
    Cardiologia; 1997 Jan; 42(1):47-50. PubMed ID: 9118154
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of angiotensin-converting enzyme gene polymorphism and serum vitamin D levels on ambulatory blood pressure measurement and left ventricular mass in Turkish hypertensive population.
    Kulah E; Dursun A; Aktunc E; Acikgoz S; Aydin M; Can M; Dursun A
    Blood Press Monit; 2007 Aug; 12(4):207-13. PubMed ID: 17625392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.